{{Rsnum
|rsid=1249675
|Gene=SLC44A5
|Chromosome=1
|position=75304940
|Orientation=minus
|GMAF=0.3347
|Gene_s=SLC44A5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 32.7 | 44.2 | 23.0
| HCB | 72.3 | 24.1 | 3.6
| JPT | 81.4 | 14.2 | 4.4
| YRI | 43.5 | 44.2 | 12.2
| ASW | 45.6 | 40.4 | 14.0
| CHB | 72.3 | 24.1 | 3.6
| CHD | 64.2 | 31.2 | 4.6
| GIH | 21.8 | 45.5 | 32.7
| LWK | 30.0 | 48.2 | 21.8
| MEX | 43.1 | 36.2 | 20.7
| MKK | 39.7 | 42.9 | 17.3
| TSI | 43.1 | 44.1 | 12.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22864933
  |Trait=Capecitabine sensitivity
  |Title=Identification of novel germline polymorphisms governing capecitabine sensitivity.
  |RiskAllele=
  |Pval=7E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}